The clean chit to Sonepat-based Maiden Pharmaceuticals over the deaths of 66 children in the Gambia will come as a relief for India’s flourishing pharma industry. It would be an error of judgement to proclaim it as a vindication of safe practices being followed in drug manufacturing units and